Oksana (Olyva) Hamidi DO MSCS
Adrenal Disease, Pituitary Disorders & Neuroendocrinology
Associate Professor
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-2800
Fax+1 214-645-2808
Dr. Hamidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Oksana Hamidi is an academic endocrinologist in the Division of Endocrinology and Metabolism at University of Texas Southwestern Medical Center in Dallas, Texas. She specializes in adrenal and pituitary tumors, hereditary neuroendocrine syndromes, adrenal insufficiency, Cushing syndrome, pheochromocytoma-paraganglioma, and congenital adrenal hyperplasia.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2018
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2012 - 2015
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2012
Certifications & Licensure
TX State License 2018 - 2026
MN State License 2015 - 2018
IL State License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.John B Buse, Steven E Kahn, Vanita R Aroda, Richard J Auchus, Timothy Bailey
Diabetes Care. 2025-04-18 - Delayed Bilateral Adrenal Enlargement in a Patient With DisseminatedInfection.Felona Gunawan, Liwei Jia, Oksana Hamidi
JCEM Case Reports. 2025-04-01 - Composite Pheochromocytoma-Paraganglioma With Ganglioneuroma: A Dual-Center Clinical Experience.Shubham Agarwal, Hussam Alkaissi, Karel Pacak, Jorge Esteban Mosquera Izurieta, Alan P Dackiw
Journal of the Endocrine Society. 2025-03-03
Press Mentions
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024May 10th, 2024- CAH Treatment 'Struggle' Points to Unmet NeedMay 16th, 2024
- UTSW Research: Female Sex Hormones, Adrenal Hyperplasia, and MoreJuly 3rd, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
